Yarrow Bioscience, Inc. — Form 8-K
Filed July 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Yarrow Bioscience filed an 8-K on July 30, 2026 reporting an event dated July 29, 2026, disclosing under Item 8.01 (Other Events). The filing document itself does not contain the substantive text of the event—only administrative metadata (EDGAR accession, document structure, and company contact information for a $32M market-cap biopharmaceutical firm). The actual event details are not provided in this filing extract.
Why this rating
Filing is administrative disclosure; substantive event details absent from provided text. Cannot assess materiality without event substance.
Extracted items
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.